Cartesian Therapeutics (RNAC)

• Market cap: $283M
• 1 day: -5.3%
• 5 days: 6.76%
• 1 month: 49.46%
• 3 months: 58.81%
• 6 months: 42.6%
• Year to date: 42.6%
• 1 year: -6.95%
• 5 years: -93.09%
• 10 years: -97.7%
• Sector: Healthcare
• Industry: Biotechnology

About: Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Employees: 75